Neuca

Neuca Profit per Employee

The Profit per Employee of Neuca (NEU.WA) as of Oct 22, 2026 is 32,933.74 PLN. In the previous year, Profit per Employee was 32,651.14 PLN — a change of 0.87% (higher).

Profit per Employee

32,933.74PLN

YoY

0.87%

Last updated:

Profit per Employee of Neuca is 2025 32,933.74 PLN. Profit per Employee of Neuca was 2024 32,651.14 PLN. It decreases by 0.87% higher compared to the previous year.

The Neuca Profit per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Profit per Employee
Date
Profit per Employee
Jan 1, 2018
20,803.13 PLN
Jan 1, 2019
24,905.80 PLN
Jan 1, 2020
30,015.03 PLN
Jan 1, 2021
31,891.41 PLN
Jan 1, 2022
29,051.23 PLN
Jan 1, 2023
30,962.96 PLN
Jan 1, 2024
32,651.14 PLN
Jan 1, 2025
32,933.74 PLN
The Neuca Profit per Employee history
YEARProfit per EmployeeYoY
32,933.74PLN+0.87%
32,651.14PLN+5.45%
30,962.96PLN+6.58%
29,051.23PLN-8.91%
31,891.41PLN+6.25%
30,015.03PLN+20.51%
24,905.80PLN+19.72%
20,803.13PLN+4.00%
20,003.60PLN-15.42%
23,650.93PLN+10.31%
21,440.30PLN+8.83%
19,701.52PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neuca Stock analysis

What does Neuca do? NEUCA SA generates revenue through the wholesale distribution of pharmaceutical products to pharmacies, leveraging its extensive network in the health market. The company also produces and sells its own branded drugs, supplements, and cosmetics, while offering clinical trials, telemedicine services, and IT solutions tailored for healthcare providers. Its e-commerce platform further supports the healthcare industry by enabling digital transactions for medical products and services. The primary buyers include pharmacies, healthcare institutions, and consumers seeking health-related products through online channels. NEUCA SA's business model integrates multiple revenue streams within the health sector, with a focus on both physical and digital distribution. The firm's own-brand products, such as pharmaceuticals and cosmetics, are sold directly to end-users and retail partners, while its IT solutions and telemedicine services target healthcare organizations. Clinical trials represent another key segment, attracting partnerships with research institutions and pharmaceutical firms. The company's operational scope spans from production to distribution, ensuring a comprehensive approach to healthcare market needs. The company's revenue is driven by its diversified portfolio, including drug distribution, branded product sales, and specialized services like telemedicine and clinical trials. Pharmacies remain the core customer segment for its wholesale operations, while e-commerce and IT solutions cater to a broader audience of healthcare providers and consumers. NEUCA SA's strategic positioning in the health market allows it to capitalize on multiple growth areas without relying on a single revenue source. Neuca is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuca stock

Profit per Employee of Neuca is 32,933.74 PLN in 2025.

Profit per Employee of Neuca changed from 32,651.14 PLN to 32,933.74 PLN, representing a 0.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Profit per Employee Neuca since 2006 – with annual values, charts, and detailed analysis.

Profit per employee measures how much net income each employee generates on average. It is a key indicator of workforce efficiency.

Profit per Employee's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Profit per Employee's Neuca historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Neuca

All Key Metrics — Neuca